Jamie Dohopolski is an associate in Sterne Kessler’s Trial & Appellate Practice Group. Jamie focuses her practice on patent litigation.

Jamie graduated from Stanford Law School, where she was an editor of Stanford Law Review and a member of Women of Stanford Law. She also participated in the Kirkwood Moot Court competition.

Jamie completed her undergraduate degrees at Duke University. Her thesis on yeast cell mating earned her graduation “with distinction” in biology with a concentration in pharmacology. She also majored in German, joining the Delta Phi Alpha honor society after studying at Humboldt University in Berlin. While at Duke, Jamie competed as a member of Duke Mock Trial.

  • A.B., Duke University
  • A.B., Biology, Duke University, with distinction
  • A.B., Germanic Languages and Literature, Duke University

  • District of Columbia
  • U.S. Court of Appeals for the Federal Circuit

  • Giles S. Rich American Inn of Court

  • The Honorable Sharon Prost, U.S. Court of Appeals for the Federal Circuit

Related News & Insights

From Jamie Dohopolski

Bylined Articles

April 10, 2024

Why Fed. Circ. Should Resolve District Split On Patent Statute

Law360 Nicholas J. Nowak, Jamie Dohopolski

Bylined Articles

February 14, 2024

Data and Trends: ITC Cases Instituted in 2023, Case Flow and Outcomes, and ITC Operations

Sterne, Kessler, Goldstein & Fox Multiple Authors

Reports

February 14, 2024

2023 ITC Section 337 Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

February 14, 2024

Sterne Kessler Publishes 2023 ITC Section 337 Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox

Bylined Articles

January 24, 2024

Amgen Inc. v. Sanofi, 598 U.S. 594 (2023)

Sterne, Kessler, Goldstein & Fox Jamie Dohopolski

Press Release

January 24, 2024

Sterne Kessler Publishes Federal Circuit IP Appeals: Summaries of Key 2023 Decisions Report

Sterne, Kessler, Goldstein & Fox

Reports

January 22, 2024

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions (8th Edition)

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm Announcements

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox

Press Release

March 7, 2022

Sterne Kessler Publishes 2021 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox

Press Release

February 7, 2022

Sterne Kessler Releases Report Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox

Reports

February 3, 2022

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

February 3, 2022

Mylan Labs. Ltd v. Janssen Pharmaceutica, N.V., 989 F.3d 1375 (Fed. Cir. 2021)

Sterne, Kessler, Goldstein & Fox Jamie Dohopolski

Bylined Articles

December 1, 2021

In Review and Moving Forward

Intellectual Property Magazine William H. Milliken, Jamie Dohopolski